Mutations in the lipoprotein lipase gene as a cause of hypertriglyceridemia and pancreatitis in Taiwan

被引:30
作者
Jap, TS [1 ]
Jenq, SF
Wu, YC
Chiu, CY
Cheng, HM
机构
[1] Vet Gen Hosp, Dept Pathol & Lab Med, Biochem Sect, Taipei 112, Taiwan
[2] Vet Gen Hosp, Dept Med, Div Endocrinol & Metab, Taipei, Taiwan
[3] Chi Mei Fdn Hosp, Dept Internal Med, Tainan, Taiwan
[4] Natl Yang Ming Univ, Taipei 112, Taiwan
关键词
hypertriglyceridemia; lipoprotein lipase gene; pancreatitis; Taiwan;
D O I
10.1097/00006676-200308000-00003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Familial lipoprotein lipase (LPL) deficiency is inherited as an autosomal recessive trait and is characterized by chylomicronemia, eruptive xanthoma, hepatosplenomegaly, and recurrent pancreatitis. Aims and Methodology: Two unrelated Chinese of Han descent with hypertriglyceridemia were enrolled in this study, and another six Han Chinese with no family history of hypertriglyceridemia and diabetes were recruited as normal controls. LPL activity was determined with use of an artificial substrate of C-14-trioleine and Arabic gum, and release of C-14 free fatty acid was determined by the liquid-liquid partitioning system. LPL mass was measured by enzyme immunoassay. Genomic DNA was extracted from EDTA-preserved whole blood, and PCR was used to amplify the nine coding exons and the minimal promoter of the LPL gene. Results: DNA sequence analysis revealed that mutations were identified in both patients; one patient had compound heterozygous mutations in codon 252 [CTG( Leu) --> GTG( Val)] and in codon 264 [TGC(Cys) --> TGa(Ter)] of exon 6, and the other patient had homozygous L252V mutation. These subjects had greater than or equal to 90% reduction in LPL mass and greater than or equal to60% reduction in LPL activity. Conclusion: The mutated and truncated LPLs caused hypertriglyceridemia in these patients in Taiwan with hypertriglyceridemia and pancreatitis.
引用
收藏
页码:122 / 126
页数:5
相关论文
共 29 条
  • [1] FAMILIAL CHYLOMICRONEMIA (TYPE-I HYPERLIPOPROTEINEMIA) DUE TO A SINGLE MISSENSE MUTATION IN THE LIPOPROTEIN-LIPASE GENE
    AMEIS, D
    KOBAYASHI, J
    DAVIS, RC
    BENZEEV, O
    MALLOY, MJ
    KANE, JP
    LEE, G
    WONG, H
    HAVEL, RJ
    SCHOTZ, MC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (04) : 1165 - 1170
  • [2] Bijvoet S, 1996, J LIPID RES, V37, P640
  • [3] BRUIN T, 1994, J LIPID RES, V35, P438
  • [4] BRUNZELL JD, 1995, METABOLIC BASIS INHE, V2, P1913
  • [5] Chan L, 2000, EUR J CLIN INVEST, V30, P33
  • [6] Genotype-Phenotype Studies of Six Novel LPL Mutations in Chinese Patients with Hypertriglyceridemia
    Chan, Lisa Y. S.
    Lam, Ching-Wan
    Mak, Ying-Tat
    Tomlinson, Brian
    Tsang, Man-Woo
    Baum, Larry
    Masarei, John R. L.
    Pang, Chi-Pui
    [J]. HUMAN MUTATION, 2002, 20 (03) : 232 - 233
  • [7] Gerdes C, 1997, CIRCULATION, V96, P733
  • [8] HETEROGENEOUS MUTATIONS IN THE HUMAN LIPOPROTEIN-LIPASE GENE IN PATIENTS WITH FAMILIAL LIPOPROTEIN-LIPASE DEFICIENCY
    GOTODA, T
    YAMADA, N
    KAWAMURA, M
    KOZAKI, K
    MORI, N
    ISHIBASHI, S
    SHIMANO, H
    TAKAKU, F
    YAZAKI, Y
    FURUICHI, Y
    MURASE, T
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (06) : 1856 - 1864
  • [9] HATA A, 1992, J BIOL CHEM, V267, P20132
  • [10] AMINO-ACID SUBSTITUTION (ILE194-]THR) IN EXON-5 OF THE LIPOPROTEIN-LIPASE GENE CAUSES LIPOPROTEIN-LIPASE DEFICIENCY IN 3 UNRELATED PROBANDS - SUPPORT FOR A MULTICENTRIC ORIGIN
    HENDERSON, HE
    MA, Y
    HASSAN, MF
    MONSALVE, MV
    MARAIS, AD
    WINKLER, F
    GUBERNATOR, K
    PETERSON, J
    BRUNZELL, JD
    HAYDEN, MR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) : 2005 - 2011